Exploring the renewed interest in psychedelic treatments for mental illnesses, including the rise of for-profit psychedelic companies and the progress of a phase three trial for MDMA-assisted therapy for PTSD.
Major trials are bringing us a step closer to seeing psychedelic substances used in therapy practice for PTSD, anxiety and depression. On this episode of All in the Mind, we take a look at where the research is currently at.